Logo

Vanderbilt Researchers to Use FGT s Data Management System to Study Genetics of Drug Side Effects

Jan 18, 2005

NEW YORK, Jan. 18 (GenomeWeb News) - First Genetic Trust will provide the VanderbiltUniversityMedicalCenterwith its genetic data management system to further study the genetics of drug side effects, the two organizations said yesterday.

 

Vanderbilt researchers plans to use FGT's web-based EnTrust study-management system to expand their research on the genetics of drug-induced prolonged QT, a side effect for many different drug classes.

 

The system allows the VUMC researchers to enroll patients referred by other clinicians electronically. FGT's platform will be used to manage online informed consent, samples, clinical data, and genetic data. First Genetic Trust is headquartered in Chicago.

 

Financial terms of the agreement were not disclosed.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.